UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 6
June-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2306967


Registration ID:
520324

Page Number

j579-j585

Share This Article


Jetir RMS

Title

ISOCRATIC RP-LC METHOD FOR COMBINED QUANTIFICATION OF THE ETODOLAC AND DEXAMETHASONE IN COMBINATION TABLETS

Abstract

It has been developed and validated an accurate, sensitive, precise, quick, and isocratic reverse phase HPLC (RP-HPLC) technique for combined quantification of Etodolac, and Dexamethasone in raw materials and pharmaceutical combined dispensing kit contains tablet dosage forms. With acetonitrile as the organic solvent, the best separation was achieved on a 250 mmx4.6 mm i.d., 5µ-particle size Inertsil®-Octadecyl-silyl-3V-Reverse-Phase-C18-column with acetonitrile as the non-polar-modifier and ortho-phosphoric acid (0.1%v/v) in water in the isocratic mode of elution as mobile phase solvent at a speed of 1.0 mL.min−1. UV detection was at 245-nm. Etodolac's was 2.0 minutes, and Dexamethasone's was 2.9 minutes. With a correlation coefficient of about 0.9999, peak-response was obtained as function of concentration over the range of 1.6-9.6 µg/mL for dexamethasone and 60-360 µg/mL for etodolac. Etodolac, and Dexamethasone were shown to have a percentage assay of 99.57, and 99.97, respectively. Etodolac, and Dexamethasone each have a limit of detection of 0.2 mcg/mL and 0.0016 mcg/mL, respectively. Etodolac, and Dexamethasone each have a limit of quantification (LOQ) of 0.6 mcg/mL and 0.0048 mcg/mL, respectively. The presence of excipients in the formulation had no effect on the assay method. The procedure is appropriate for use in QC- laboratories since it is quick and precise.

Key Words

Etodolac, Dexamethasone, Isocratic-RP-HPLC, and Fixed dosage forms

Cite This Article

"ISOCRATIC RP-LC METHOD FOR COMBINED QUANTIFICATION OF THE ETODOLAC AND DEXAMETHASONE IN COMBINATION TABLETS ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 6, page no.j579-j585, June-2023, Available :http://www.jetir.org/papers/JETIR2306967.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"ISOCRATIC RP-LC METHOD FOR COMBINED QUANTIFICATION OF THE ETODOLAC AND DEXAMETHASONE IN COMBINATION TABLETS ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 6, page no. ppj579-j585, June-2023, Available at : http://www.jetir.org/papers/JETIR2306967.pdf

Publication Details

Published Paper ID: JETIR2306967
Registration ID: 520324
Published In: Volume 10 | Issue 6 | Year June-2023
DOI (Digital Object Identifier):
Page No: j579-j585
Country: Hyderabad, Telangana, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00078

Print This Page

Current Call For Paper

Jetir RMS